CVE-2012-1460: The Gzip file parser in Antiy Labs AVL SDK 2.0.3.7, Quick Heal (aka Cat QuickHeal) 11.00, Command Antivirus 5.2.11.5, eSafe 7.0.17.0, F-Prot…
Noroxi assessment
Priority: Plan (action score 45/100)
- The sources we track (CISA KEV, Exploit-DB, Metasploit, Nuclei, GitHub) show no public exploit code or exploitation in the wild.
- Probability of exploitation in the next 30 days: 93.8% (FIRST EPSS); higher than 99.8% of all records.
- According to the record, no fixed version is available yet.
Add it to your regular patch cycle. Update when a fix is released; follow the vendor's advisory.
Generated automatically from the record's data: CVSS (NVD and CNA), CISA KEV and SSVC, FIRST EPSS, exploit sources, fixed versions. How we calculate it
Primary sources: NVD · CVE.org · FIRST EPSS
The Gzip file parser in Antiy Labs AVL SDK 2.0.3.7, Quick Heal (aka Cat QuickHeal) 11.00, Command Antivirus 5.2.11.5, eSafe 7.0.17.0, F-Prot Antivirus 4.6.2.117, Jiangmin Antivirus 13.0.900, K7 AntiVirus 9.77.3565, and VBA32 3.12.14.2 allows remote attackers to bypass malware detection via a .tar.gz file with stray bytes at the end. NOTE: this may later be SPLIT into multiple CVEs if additional information is published showing that the error occurred independently in different Gzip parser implementations.
- Published
- Mar 21, 2012
- Updated
- Jun 16, 2026
- EPSS
- 93.8% · 99th percentile
- CWE
- CWE-264
Report tools
Action score
45
Add it to your regular patch cycle.
- CVSS
- 17 / 40 · 4.3 / 10
- CISA KEV
- 0 / 30 · Not listed
- EPSS
- 28 / 30 · 93.8%
Get told when this record changes
- Not in KEV: no record of exploitation in the wild
- No public exploit code on record
- No fixed version yet
If any of these changes, we'll tell you in the daily email digest.
Is your version affected? Check itNoroxi analysis
What does it mean in your environment?
The assessment above is generated automatically from the record's data; it doesn't know your environment. Our team verifies on your systems whether this vulnerability is actually exploitable and which mitigation is enough.
We use this product, ask for helpAffected systems
Is your version affected?
Pick the product and type the version you run. It's compared with this record's version ranges in your browser; the version isn't sent anywhere.
| Vendor | Product | CPE |
|---|---|---|
| antiy | avl sdk | cpe:2.3:a:antiy:avl_sdk |
| aladdin | esafe | cpe:2.3:a:aladdin:esafe |
| anti-virus | vba32 | cpe:2.3:a:anti-virus:vba32 |
| authentium | command antivirus | cpe:2.3:a:authentium:command_antivirus |
| cat | quick heal | cpe:2.3:a:cat:quick_heal |
| f-prot | f-prot antivirus | cpe:2.3:a:f-prot:f-prot_antivirus |
| jiangmin | jiangmin antivirus | cpe:2.3:a:jiangmin:jiangmin_antivirus |
| k7computing | antivirus | cpe:2.3:a:k7computing:antivirus |
Affected versions
NVD version ranges (for catalog products). Add the product to your stack with a version and matching uses these.
- aladdin esafe7.0.17.0
- anti-virus vba323.12.14.2
- antiy avl sdk2.0.3.7
- authentium command antivirus5.2.11.5
- cat quick heal11.00
- f-prot f-prot antivirus4.6.2.117
- jiangmin jiangmin antivirus13.0.900
- k7computing antivirus9.77.3565
Same product
antiy: all recordsOther highest-scoring records for the same primary product.
- CVE-2012-1425The TAR file parser in Avira AntiVir 7.11.1.163, Antiy Labs AVL SDK 2.0.3.7, Quick Heal (aka Cat QuickHeal) 11.00, Emsisoft Anti-Malware…45Plan
- CVE-2012-1424The TAR file parser in Antiy Labs AVL SDK 2.0.3.7, Quick Heal (aka Cat QuickHeal) 11.00, Jiangmin Antivirus 13.0.900, Norman Antivirus 6.06.43Plan
Remediation
Which version to upgrade to
Fix versions compiled from the vendor, package registries and Microsoft. Verify the vendor's note before upgrading.
No fix version is recorded for this entry. Check the references for vendor advisories.
Exploit status
No known public exploit
No public exploit has been observed yet. That doesn't mean you're safe, only that the bar is a little higher.
Research context
For pentesters and researchers: attack profile, score disagreement, timeline, patch commits, credits, variant and chain candidates, bug bounty scope. All derived from existing data; no exploit code.
Timeline
From publication to today: proof of concept, Metasploit module, CISA KEV and fix record. Dates are as reported by the sources.
No dated events beyond publication.
Bug bounty scope
The product’s vendor appears in a public program. Matched by name; verify the scope text in the program.
Not on record for this CVE: EPSS history · patch commit or PR link · researcher credit · variant or chain candidate.
Technical details
Attack conditions
If successful
- Confidentiality
- none
- Integrity
- P · data or configuration can be modified
- Availability
- none
- Attack complexity
- M
- Confidentiality impact
- None
- Integrity impact
- P
- Availability impact
- None
Weakness class (CWE)
CWE-264 · Permissions, Privileges, and Access ControlsCVSS vector
AV:N/AC:M/Au:N/C:N/I:P/A:N
nvd-primary
Attack context
MITRE CAPEC attack patterns and ATT&CK techniques for this weakness class (CWE). A starting point for detection rules and threat hunting.
MITRE has no CAPEC/ATT&CK mapping for this CWE.
Change log (0)
No changes recorded on tracked fields yet. Score, KEV, exploit maturity and fix status changes appear here.
References
Show all references (3 more)Show less
Vendor advisories and official records. Exploit/PoC links are deliberately left out.